Status: Phase 3
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Hypersensitivity Phase 3 ClinicalTrials
Conjunctivitis; Hypersensitivity; Rhinitis Phase 2 ClinicalTrials
CONTENTS